Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1990 1
1991 1
1992 2
1994 1
1995 8
1996 5
1997 4
1998 10
1999 2
2000 11
2001 5
2002 6
2003 7
2004 6
2005 6
2006 6
2007 6
2008 10
2009 10
2010 11
2011 4
2012 8
2013 8
2014 7
2015 9
2016 5
2017 4
2018 4
2019 7
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

162 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of anxiety disorders.
Bandelow B, Michaelis S, Wedekind D. Bandelow B, et al. Dialogues Clin Neurosci. 2017 Jun;19(2):93-107. doi: 10.31887/DCNS.2017.19.2/bbandelow. Dialogues Clin Neurosci. 2017. PMID: 28867934 Free PMC article. Review.
Efficacy of treatments for anxiety disorders: a meta-analysis.
Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Bandelow B, et al. Int Clin Psychopharmacol. 2015 Jul;30(4):183-92. doi: 10.1097/YIC.0000000000000078. Int Clin Psychopharmacol. 2015. PMID: 25932596 Review.
Epidemiology of anxiety disorders in the 21st century.
Bandelow B, Michaelis S. Bandelow B, et al. Dialogues Clin Neurosci. 2015 Sep;17(3):327-35. doi: 10.31887/DCNS.2015.17.3/bbandelow. Dialogues Clin Neurosci. 2015. PMID: 26487813 Free PMC article.
Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
Bandelow B. Bandelow B. Adv Exp Med Biol. 2020;1191:347-365. doi: 10.1007/978-981-32-9705-0_19. Adv Exp Med Biol. 2020. PMID: 32002937 Review.
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.
Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P. Bandelow B, et al. World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. World J Biol Psychiatry. 2017. PMID: 27419272 Free PMC article. Review.
Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis.
Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH. Strawbridge R, et al. Among authors: bandelow b. Br J Psychiatry. 2019 Jan;214(1):42-51. doi: 10.1192/bjp.2018.233. Epub 2018 Nov 20. Br J Psychiatry. 2019. PMID: 30457075
Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
Timäus C, Meiser M, Bandelow B, Engel KR, Paschke AM, Wiltfang J, Wedekind D. Timäus C, et al. Among authors: bandelow b. BMC Psychiatry. 2019 Dec 12;19(1):393. doi: 10.1186/s12888-019-2377-z. BMC Psychiatry. 2019. PMID: 31830934 Free PMC article.
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD. Bandelow B, et al. Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. Epub 2012 Apr 30. Int J Psychiatry Clin Pract. 2012. PMID: 22540422
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.
Bandelow B, Baldwin D, Abelli M, Altamura C, Dell'Osso B, Domschke K, Fineberg NA, Grünblatt E, Jarema M, Maron E, Nutt D, Pini S, Vaghi MM, Wichniak A, Zai G, Riederer P. Bandelow B, et al. World J Biol Psychiatry. 2016 Aug;17(5):321-65. doi: 10.1080/15622975.2016.1181783. Epub 2016 Jul 12. World J Biol Psychiatry. 2016. PMID: 27403679
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, Malizia A, McCrone P, Nabarro D, O'Neill C, Scott J, van der Wee N, Wittchen HU. Baldwin DS, et al. Among authors: bandelow b. J Psychopharmacol. 2014 May;28(5):403-39. doi: 10.1177/0269881114525674. Epub 2014 Apr 8. J Psychopharmacol. 2014. PMID: 24713617
162 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback